129 related articles for article (PubMed ID: 37679280)
1. Dosing of iodixanol for predicting acute kidney injury in patients undergoing elective percutaneous coronary intervention.
Chen Z; Zhao N; Zhang Y; Zhao R; Zhao X
Eur J Intern Med; 2023 Dec; 118():136-138. PubMed ID: 37679280
[No Abstract] [Full Text] [Related]
2. Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media.
Azzalini L; Vilca LM; Lombardo F; Poletti E; Laricchia A; Beneduce A; Maccagni D; Demir OM; Slavich M; Giannini F; Carlino M; Margonato A; Cappelletti A; Colombo A
Int J Cardiol; 2018 Dec; 273():69-73. PubMed ID: 30196995
[TBL] [Abstract][Full Text] [Related]
3. Effects of a High Dose of the Contrast Medium Iodixanol on Renal Function in Patients Following Percutaneous Coronary Intervention.
Zhao N; Chen Z; Zhou Y; Xu Q; Xu Z; Tong W; Li L; Mao Q; Song Y; Jin J; Huang L; Azzalini L; Zhao X
Angiology; 2021 Feb; 72(2):145-152. PubMed ID: 32911955
[TBL] [Abstract][Full Text] [Related]
4. Iodixanol-associated acute kidney injury and prognosis in patients undergoing elective percutaneous coronary intervention: a prospective, multi-center study.
Chen Z; Mao Q; Xiang L; Zhou D; Jiang Y; Zhao N; Huang L; Azzalini L; Zhao X
Eur Radiol; 2023 Dec; 33(12):9444-9454. PubMed ID: 37480548
[TBL] [Abstract][Full Text] [Related]
5. Economic impact of contrast-induced acute kidney injury associated with invasive cardiology: role of iso-osmolar contrast media in Germany, Italy, Poland, and Spain.
De Francesco M; Ronco C; Wacinski PJ; Wessely R; Hernández F; Lamotte M
J Med Econ; 2016; 19(2):158-68. PubMed ID: 26451530
[TBL] [Abstract][Full Text] [Related]
6. The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
Reed MC; Moscucci M; Smith DE; Share D; LaLonde T; Mahmood SA; D'Haem C; McNamara R; Greenbaum A; Gurm HS
J Invasive Cardiol; 2010 Oct; 22(10):467-72. PubMed ID: 20944185
[TBL] [Abstract][Full Text] [Related]
7. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
[TBL] [Abstract][Full Text] [Related]
8. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
9. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
[TBL] [Abstract][Full Text] [Related]
10. Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.
Zhang J; Jiang Y; Rui Q; Chen M; Zhang N; Yang H; Zhou Y
Medicine (Baltimore); 2018 May; 97(18):e0617. PubMed ID: 29718868
[TBL] [Abstract][Full Text] [Related]
11. Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography.
Breglia A; Godi I; Virzì GM; Guglielmetti G; Iannucci G; De Cal M; Brocca A; Carta M; Giavarina D; Ankawi G; Passannante A; Yun X; Biolo G; Ronco C
Cardiorenal Med; 2020; 10(2):125-136. PubMed ID: 32036364
[TBL] [Abstract][Full Text] [Related]
12. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD
Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of aspartate aminotransferase-to-alanine aminotransferase ratio for contrast-associated acute kidney injury in patients undergoing elective percutaneous coronary intervention.
He HM; He C; Zhang SC; You ZB; Lin XQ; Luo MQ; Lin MQ; Guo YS; Zheng WP; Lin KY
J Cardiol; 2022 May; 79(5):618-625. PubMed ID: 34857433
[TBL] [Abstract][Full Text] [Related]
14. Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapy.
Xiong HL; Peng M; Jiang XJ; Dong H; Che WQ; Chen Y; Zou YB; Xu B; Yang YJ; Gao RL
Int Urol Nephrol; 2018 Oct; 50(10):1879-1886. PubMed ID: 29948863
[TBL] [Abstract][Full Text] [Related]
15. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium.
Karlsberg RP; Dohad SY; Sheng R;
J Vasc Interv Radiol; 2011 Aug; 22(8):1159-65. PubMed ID: 21570871
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Model for Predicting the Risk of Acute Kidney Injury Associated With Contrast Volume Levels During Percutaneous Coronary Intervention.
Huang C; Li SX; Mahajan S; Testani JM; Wilson FP; Mena CI; Masoudi FA; Rumsfeld JS; Spertus JA; Mortazavi BJ; Krumholz HM
JAMA Netw Open; 2019 Nov; 2(11):e1916021. PubMed ID: 31755952
[TBL] [Abstract][Full Text] [Related]
17. Revising the Maximal Contrast Dose for Predicting Acute Kidney Injury following Coronary Intervention.
Hattar L; Assaker JP; Aoun J; Price LL; Carrozza J; Jaber BL
Am J Nephrol; 2021; 52(4):328-335. PubMed ID: 33827080
[TBL] [Abstract][Full Text] [Related]
18. Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Wi J; Ko YG; Kim JS; Kim BK; Choi D; Ha JW; Hong MK; Jang Y
Heart; 2011 Nov; 97(21):1753-7. PubMed ID: 21602521
[TBL] [Abstract][Full Text] [Related]
19. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
[TBL] [Abstract][Full Text] [Related]
20. Pre-Procedural N-Terminal Pro-B Type Natriuretic Peptide Predicts Contrast-Induced Acute Kidney Injury and Long-Term Outcome in Elderly Patients After Elective Percutaneous Coronary Intervention.
Lin KY; Wu ZY; You ZB; Zheng WP; Lin CJ; Jiang H; Ruan JM; Guo YS; Zhu PL
Int Heart J; 2018 Sep; 59(5):926-934. PubMed ID: 30158378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
